after a mean follow-up of 19 +/- 7 months , 12 of 14 patients receiving sotalol treatment had successful suppression of ventricular premature complexes ( 60 +/- 85/hr ) and remained clinically free of sustained vt , except 2 who needed additional antiarrhythmic drugs to suppress the recurrent sustained vt .
C0037707
sotalol
C0003195
antiarrhythmic drugs